Literature DB >> 15364586

The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization.

Roy R Hantgan1, Mary C Stahle, John H Connor, Douglas S Lyles, David A Horita, Mattia Rocco, Chandrasekaran Nagaswami, John W Weisel, Mary Ann McLane.   

Abstract

We have employed echistatin, a 5.4 kDa snake venom disintegrin, as a model protein to investigate the paradox that small ligand-mimetics can bind to the resting alphaIIbbeta3 integrin while adhesive macromolecules cannot. We characterized the interactions between purified human alphaIIbbeta3 and two recombinant echistatin variants: rEch (1-49) M28L, chosen for its selectivity toward beta3-integrins, and rEch (1-40) M28L, a carboxy-terminal truncation mutant. While both contain an RGD integrin targeting sequence, only rEch (1-49) M28L was an effective inhibitor of alphaIIbbeta3 function. Electron microscopy of rotary shadowed specimens yielded a variety of alphaIIbbeta3 conformers ranging from compact, spherical particles (maximum dimension 22 nm) to the classical "head with two tails" forms (32 nm). The population of larger particles (42-56 nm) increased from 17% to 28% in the presence of rEch (1-49) M28L, indicative of ligand-induced oligomerization. Sedimentation velocity measurements demonstrated that both full length and truncated echistatin perturbed alphaIIbbeta3's solution structure, yielding slower-sedimenting open conformers. Dynamic light scattering showed that rEch (1-49) M28L protected alphaIIbbeta3 from thermal aggregation, raising its transition mid-point from 46 degrees C to 69 degrees C; a smaller shift resulted with rEch (1-40) M28L. Sedimentation equilibrium demonstrated that both echistatin ligands induced substantial alphaIIbbeta3 dimerization. van't Hoff analysis revealed a pattern of entropy/enthalpy compensation similar to tirofiban, a small RGD ligand-mimetic that binds tightly to alphaIIbbeta3, but yields smaller conformational perturbations than echistatin. We propose that echistatin may serve as a paradigm for understanding multidomain adhesive macromolecules because its ability to modulate alphaIIbbeta3's structure resides on an RGD loop, while full disintegrin activity requires an auxiliary site that includes the carboxy-terminal nine amino acid residues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364586     DOI: 10.1016/j.jmb.2004.08.009

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  9 in total

1.  Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.

Authors:  Roy R Hantgan; Mary C Stahle; John H Connor; David A Horita; Mattia Rocco; Mary A McLane; Sergiy Yakovlev; Leonid Medved
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

2.  Integrin conformational regulation: uncoupling extension/tail separation from changes in the head region by a multiresolution approach.

Authors:  Mattia Rocco; Camillo Rosano; John W Weisel; David A Horita; Roy R Hantgan
Journal:  Structure       Date:  2008-06       Impact factor: 5.006

3.  Isolation and Functional Identification of an Antiplatelet RGD-Containing Disintegrin from Cerastes cerastes Venom.

Authors:  Meriem Ameziani; Fatah Chérifi; Hamida Kiheli; Samah Saoud; Ghania Hariti; Safia Kellou-Taîri; Fatima Laraba-Djebari
Journal:  Protein J       Date:  2020-09-22       Impact factor: 2.371

4.  On the mechanism of αC polymer formation in fibrin.

Authors:  Galina Tsurupa; Igor Pechik; Rustem I Litvinov; Roy R Hantgan; Nico Tjandra; John W Weisel; Leonid Medved
Journal:  Biochemistry       Date:  2012-03-15       Impact factor: 3.162

Review 5.  Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis.

Authors:  Alexandra H Smith; Hiroko Fujii; Michael A Kuliszewski; Howard Leong-Poi
Journal:  J Cardiovasc Transl Res       Date:  2011-05-03       Impact factor: 4.132

6.  Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates.

Authors:  Steven B Mizel; Aaron H Graff; Nammalwar Sriranganathan; Sean Ervin; Cynthia J Lees; Mark O Lively; Roy R Hantgan; Michael J Thomas; James Wood; Brian Bell
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

Review 7.  Applications of snake venom components to modulate integrin activities in cell-matrix interactions.

Authors:  Cezary Marcinkiewicz
Journal:  Int J Biochem Cell Biol       Date:  2013-06-26       Impact factor: 5.085

Review 8.  Biomedical applications of snake venom: from basic science to autoimmunity and rheumatology.

Authors:  Carlos A Cañas; Santiago Castaño-Valencia; Fernando Castro-Herrera; Felipe Cañas; Gabriel J Tobón
Journal:  J Transl Autoimmun       Date:  2020-12-14

Review 9.  Recombinant and Chimeric Disintegrins in Preclinical Research.

Authors:  Victor David; Barbara Barbosa Succar; João Alfredo de Moraes; Roberta Ferreira Gomes Saldanha-Gama; Christina Barja-Fidalgo; Russolina Benedeta Zingali
Journal:  Toxins (Basel)       Date:  2018-08-07       Impact factor: 4.546

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.